Cargando…
G6PD deficiency in malaria endemic areas of Nepal
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. The World Health Organization (WHO) recommends G6PD screening before providing primaquine as a radical treatment ag...
Autores principales: | Marasini, Baburam, Lal, Bibek Kumar, Thapa, Suman, Awasthi, Kiran Raj, Bajracharya, Bijay, Khanal, Pratik, Neupane, Sanjeev, Jha, Shambhu Nath, Acharya, Sanjaya, Iama, Smriti, Koirala, Madan, Koirala, Dinesh, Bhandari, Suresh, Mahato, Ram Kumar, Chaudhary, Arun, Ghimire, Pramin, Magar, Rahachan Gharti, Bhattarai, Rajan Kumar, Gornsawun, Gornpan, Penpitchaporn, Pimsupah, Bancone, Germana, Acharya, Bhim Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425560/ https://www.ncbi.nlm.nih.gov/pubmed/32787970 http://dx.doi.org/10.1186/s12936-020-03359-6 |
Ejemplares similares
-
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient
por: Pal, Sampa, et al.
Publicado: (2019) -
The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019) -
Outbreak of acute undifferentiated febrile illness in Kathmandu, Nepal: clinical and epidemiological investigation
por: Pokharel, Sunil, et al.
Publicado: (2020) -
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood
por: Bancone, Germana, et al.
Publicado: (2018) -
Contribution of genetic factors to high rates of neonatal hyperbilirubinaemia on the Thailand-Myanmar border
por: Bancone, Germana, et al.
Publicado: (2022)